Vanguard Group »

Spero Therapeutics shares owned by Vanguard Group

Quarter-by-quarter ownership of Spero Therapeutics (SPRO) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Spero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Spero Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Spero Therapeutics by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 1.6M 1.47
2023-09-30 $1.9M 1.6M 1.21
2023-06-30 $2.2M 1.5M 1.45
2023-03-31 $2.1M 1.4M 1.45
2022-12-31 $1.8M 1.1M 1.73
2022-06-30 $924k 1.2M 0.74
2022-03-31 $12M 1.4M 8.70
2021-09-30 $24M 1.3M 18.41
2021-06-30 $18M 1.3M 13.96
2021-03-31 $16M 1.1M 14.73
2020-12-31 $22M 1.1M 19.39
2020-09-30 $10M 929k 11.16
2020-06-30 $9.9M 735k 13.53
2020-03-31 $5.1M 629k 8.08
2019-12-31 $4.8M 496k 9.62
2019-09-30 $5.3M 497k 10.62
2019-03-31 $5.3M 418k 12.75
2018-12-31 $1.0M 163k 6.19
2018-09-30 $4.8M 455k 10.52
2018-06-30 $1.8M 125k 14.61
2018-03-31 $1.6M 111k 14.24
2017-12-31 $535k 46k 11.75